Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Prezista 100mg/ml oral suspension
0503010ACBBAFAF
|
Prezista | Darunavir | Infections | No data available |
|
Prezista 150mg tablets
0503010ACBBAEAE
|
Prezista | Darunavir | Infections | No data available |
|
Prezista 300mg tablets
0503010ACBBAAAA
|
Prezista | Darunavir | Infections | No data available |
|
Prezista 400mg tablets
0503010ACBBABAB
|
Prezista | Darunavir | Infections | No data available |
|
Prezista 600mg tablets
0503010ACBBACAC
|
Prezista | Darunavir | Infections | No data available |
|
Prezista 75mg tablets
0503010ACBBADAD
|
Prezista | Darunavir | Infections | No data available |
|
Prezista 800mg tablets
0503010ACBBAGAG
|
Prezista | Darunavir | Infections | No data available |
|
Prialt 100micrograms/1ml solution for infusion vials
1502010X0BBAAAA
|
Prialt | Ziconotide acetate | Anaesthesia | No data available |
|
Prialt 500micrograms/5ml solution for infusion vials
1502010X0BBABAB
|
Prialt | Ziconotide acetate | Anaesthesia | No data available |
|
Prickly Ash bark tincture
190606000BCWAA0
|
Proprietary compound preparation BNF 1906060 | Other tincture preparations | Other Drugs and Preparations | No data available |
|
Priligy 30mg tablets (Imported)
0704060A0BBAAAA
|
Priligy | Dapoxetine hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Priligy 60mg tablets (Imported)
0704060A0BBABAB
|
Priligy | Dapoxetine hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Prilocaine 200mg/20ml solution for injection vials
1502010S0AAACAC
|
Prilocaine hydrochloride | Prilocaine hydrochloride | Anaesthesia | No data available |
|
Prilocaine 54mg/Felypressin 0.054units/1.8ml inj
1502010S0AAAIAI
|
Prilocaine hydrochloride | Prilocaine hydrochloride | Anaesthesia | No data available |
|
Prilocaine 66mg/Felypressin 0.066units/2.2ml inj
1502010S0AAAJAJ
|
Prilocaine hydrochloride | Prilocaine hydrochloride | Anaesthesia | No data available |
|
Prilocaine 66mg/Felypressin 1.19microg/2.2ml inj cart
1502010S0AAAKAK
|
Prilocaine hydrochloride | Prilocaine hydrochloride | Anaesthesia | No data available |
|
Prim-Air Kas II filter cassette
20050300220
|
Prim-Air Kas II filter cassette | Tracheostomy & Laryngectomy Appliances | Dressings | No data available |
|
Prim-Air Phon I filter cassette
20050300221
|
Prim-Air Phon I filter cassette | Tracheostomy & Laryngectomy Appliances | Dressings | No data available |
|
Prim-Air Phon I High Flow filter cassette
20050300229
|
Prim-Air Phon I High Flow filter cassette | Tracheostomy & Laryngectomy Appliances | Dressings | No data available |
|
Prim-Air Phon II filter cassette
20050300222
|
Prim-Air Phon II filter cassette | Tracheostomy & Laryngectomy Appliances | Dressings | No data available |
|
Prim-Air Strip fine plaster oval
20050300226
|
Prim-Air Strip fine plaster oval | Tracheostomy & Laryngectomy Appliances | Dressings | No data available |
|
Prim-Air Strip fine plaster round
20050300225
|
Prim-Air Strip fine plaster round | Tracheostomy & Laryngectomy Appliances | Dressings | No data available |
|
Prim-Air Strip firm plaster oval
20050300224
|
Prim-Air Strip firm plaster oval | Tracheostomy & Laryngectomy Appliances | Dressings | No data available |
|
Prim-Air Strip firm plaster round
20050300223
|
Prim-Air Strip firm plaster round | Tracheostomy & Laryngectomy Appliances | Dressings | No data available |
|
Prim-Air Strip special plaster oval
20050300228
|
Prim-Air Strip special plaster oval | Tracheostomy & Laryngectomy Appliances | Dressings | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.